A case of malignant melanoma after repeated recurrent dysplastic nevi |
Jeong, Dae Kyun
(Department of Plastic and Reconstructive Surgery, Pusan National University School of Medicine)
Bae, Yong Chan (Department of Plastic and Reconstructive Surgery, Pusan National University School of Medicine) Lee, So Jeong (Department of Pathology, Pusan National University School of Medicine) Kim, Hoon Soo (Department of Dermatology, Pusan National University School of Medicine) Choi, Young Jin (Department of Internal Medicine, Pusan National University School of Medicine) |
1 | Tucker MA. Melanoma epidemiology. Hematol Oncol Clin North Am 2009;23:383-95. DOI |
2 | Carey WP Jr, Thompson CJ, Synnestvedt M, Guerry D 4th, Halpern A, Schultz D, et al. Dysplastic nevi as a melanoma risk factor in patients with familial melanoma. Cancer 1994;74:3118-25. DOI |
3 | Burden AD, Newell J, Andrew N, Kavanagh G, Connor JM, MacKie RM. Genetic and environmental influences in the development of multiple primary melanoma. Arch Dermatol 1999;135:261-5. |
4 | Masri GD, Clark WH Jr, Guerry D 4th, Halpern A, Thompson CJ, Elder DE. Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease. J Am Acad Dermatol 1990;22(6 Pt 1):1042-8. DOI |
5 | Weinstock MA, Barnhill RL, Rhodes AR, Brodsky GL. Reliability of the histopathologic diagnosis of melanocytic dysplasia. The Dysplastic Nevus Panel Arch Dermatol 1997;133:953-8. DOI |
6 | Bergman W, van Voorst Vader PC, Ruiter DJ. Dysplastic nevi and the risk of melanoma: a guideline for patient care. Nederlandse Melanoom Werkgroep van de Vereniging voor Integrale Kankercentra. Ned Tijdschr Geneeskd 1997;141:2010-4. |
7 | Gandini S, Sera F, Cattaruzza MS, Pasquini P, Abeni D, Boyle P, et al. Meta-analysis of risk factors for cutaneous melanoma: I. common and atypical naevi. Eur J Cancer 2005;41:28-44. DOI |
8 | Tucker MA, Fraser MC, Goldstein AM, Struewing JP, King MA, Crawford JT, et al. A natural history of melanomas and dysplastic nevi: an atlas of lesions in melanoma-prone families. Cancer 2002;94:3192-209. DOI |
9 | Skender-Kalnenas TM, English DR, Heenan PJ. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma? J Am Acad Dermatol 1995;33:1000-7. DOI |
10 | Bevona C, Goggins W, Quinn T, Fullerton J, Tsao H. Cutaneous melanomas associated with nevi. Arch Dermatol 2003;139:1620-4. DOI |
11 | King R, Hayzen BA, Page RN, Googe PB, Zeagler D, Mihm MC Jr. Recurrent nevus phenomenon: a clinicopathologic study of 357 cases and histologic comparison with melanoma with regression. Mod Pathol 2009;22:611-7. DOI |
12 | Goodson AG, Florell SR, Boucher KM, Grossman D. A decade of melanomas: identification of factors associated with delayed detection in an academic group practice. Dermatol Surg 2011;37:1620-30. DOI |
13 | Kim CC, Swetter SM, Curiel-Lewandrowski C, Grichnik JM, Grossman D, Halpern AC, et al. Addressing the knowledge gap in clinical recommendations for management and complete excision of clinically atypical nevi/dysplastic nevi: Pigmented Lesion Subcommittee consensus statement. JAMA Dermatol 2015;151:212-8. DOI |
14 | Schoenfeld RJ, Pinkus H. The recurrence of nevi after incomplete removal. AMA Arch Derm 1958;78:30-5. DOI |
15 | Blum A, Hofmann-Wellenhof R, Marghoob AA, Argenziano G, Cabo H, Carrera C, et al. Recurrent melanocytic nevi and melanmas in dermoscopy: results of a multicenter study of the International Dermoscopy Society. JAMA Dermatol 2014;150:138-45. DOI |